Baystate Health (Springfield, USA) has announced it was previously selected to participate in a clinical trial intended to ...

Perfuze has announced the publication of a peer-reviewed study in Clinical Neuroradiology comparing three aspiration ...

Anaconda Biomed today announced the closing of a US$56 million financing round with participation from new and existing investors. Proceeds will support product development and clinical work, ...

Hyperfine has announced that it has completed enrolment in the Contrast PMR study—a prospective, multicentre clinical study ...

As the stroke community continues to construct a greater understanding of the various factors that influence patient outcomes, many have called for more nuanced alternatives to the modified Rankin ...

Subsense—an artificial intelligence (AI)-native neurotechnology company developing non-surgical, nanoparticle-based brain-computer interfaces (BCIs)—has announced a major expansion of its AI-driven ...

Cerevasc today announced the appointment of Tony Kingsley as its new president and chief executive officer (CEO), with Dan ...

Cercare Medical has announced an educational collaboration with the European Society of Neuroradiology (ESNR) in support of Perfusion Summit 2027 (29–30 April, Milan, Italy)—the company’s flagship ...

Earlier this month, at the 18th European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), the society introduced its new ...

XCath Robotics has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to ...

Cerevasc announced today it has successfully completed the initial closing of an US$85 million Series C financing led by Piper Sandler Merchant Banking with participation from Johnson & Johnson (J&J) ...